Reactive Oxygen Species (ROS)-Based Nanomedicine

Abstract

Reactive oxygen species (ROS) play an essential role in regulating various physiological functions of living organisms. The intrinsic biochemical properties of ROS, which underlie the mechanisms necessary for the growth, fitness, or aging of living organisms, have been driving researchers to take full advantage of these active chemical species for contributing to medical advances. Thanks to the remarkable advances in nanotechnology, great varieties of nanomaterials with unique ROS-regulating properties have been explored to guide the temporospatial dynamic behaviors of ROS in biological milieu, which contributes to the emergence of a new-generation therapeutic methodology, i.e., nanomaterial-guided in vivo ROS evolution for therapy. The interdependent relationship between ROS and their corresponding chemistry, biology, and nanotherapy leads us to propose the concept of “ROS science”, which is believed to be an emerging scientific discipline that studies the chemical mechanisms, biological effects, and nanotherapeutic applications of ROS. In this review, state-of-art studies concerning recent progresses on ROS-based nanotherapies have been summarized in detail, with an emphasis on underlying material chemistry of nanomaterials by which ROS are generated or scavenged for improved therapeutic outcomes. Furthermore, key scientific issues in the evolution of ROS-based cross-disciplinary fields have also been discussed, aiming to unlock the innate powers of ROS for optimized therapeutic efficacies. We expect that our demonstration on this evolving field will be beneficial to the further development of ROS-based fundamental researches and clinical applications.

Glycyrrhizic‐Acid‐Based Carbon Dots with High Antiviral Activity by Multisite Inhibition Mechanisms

“…Reactive oxygen species (ROS) play an essential role in regulating various physiological diseases, such as brain diseases, inflammatory diseases, cardiovascular diseases, bacterial infection, and so on 67. Viral infection causes an increase in intracellular ROS, thereby blocking the signaling pathways in the body's natural immunity.…”

A Metal‐Organic Framework (MOF) Fenton Nanoagent‐Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition

“…Recent development of catalytic chemistry provides us with feasible tools to harness redox reactions for biochemical applications, by introducing nanocatalysts into specific biological milieu to actuate redox reactions for triggering therapeutic effect 7. These nanocatalytic medicines can initiate Fenton‐like reactions in cancer cells specifically to disproportionate H 2 O 2 into highly toxic •OH, which oxidizes and inactivates ambient cellular proteins and organelles instantaneously 8. Of note, the accumulation of these damaged proteins and organelles can further lead to genotoxic ROS generation, metabolic insufficiency, and increased proteotoxicty,9 resulting in a second, continuous and amplified toxic effect.…”

FeS@BSA Nanoclusters to Enable H2S‐Amplified ROS‐Based Therapy with MRI Guidance

“…Therapeutic approaches mediated by reactive oxygen species (ROS) have received tremendous success in the exploration of cancer treatment. [ 1 ] The elevated ROS content within cells leads to oxidative damage to lipids, proteins, and DNA, and consequently the apoptosis. [ 2 ] Recent endeavor has been pursued on the exploration of therapeutic systems that may effectively response to the tumor microenvironment to trigger cell ferroptosis.…”